Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026
Go back to Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026| (NASDAQ: SYRE) | Delayed: 93.12 +1.72 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.40 | 52 Week High | $ | |||
| Open | $92.78 | 52 Week Low | $ | |||
| Day High | $95.17 | P/E | N/A | |||
| Day Low | $92.32 | EPS | $ | |||
| Volume | 475,993 | |||||



